Target intelligence / Profile preview

Keratin and other skin surface components

Molecular classification
Structural protein, Intermediate filament, Other
01

Overview

Keratin and other skin surface components, primarily located within the stratum corneum, constitute the body's essential physical and chemical barrier against environmental pathogens, dehydration, and mechanical stress (StatPearls, 2023). Keratins are a group of fibrous structural proteins that form intermediate filaments, providing mechanical stability to keratinocytes, while other components such as ceramides, cholesterol, and free fatty acids form a lipid matrix that prevents transepidermal water loss (NCBI, 2022). In pathological states like psoriasis, ichthyosis, or keratosis pilaris, there is an abnormal accumulation of keratin (hyperkeratosis) or a failure in the desquamation process, leading to thickened, scaly skin (PubMed, 2021). Therapeutic strategies targeting these components often utilize keratolytic agents, such as salicylic acid, urea, or alpha-hydroxy acids, which work by disrupting the adhesion between corneocytes or by softening keratin through hydration (PubChem, 2024). While these treatments are effective for managing hyperkeratotic disorders, they can lead to side effects such as skin irritation, increased sensitivity to ultraviolet radiation, and temporary impairment of the skin's protective barrier (NIH, 2023).

Other names
Stratum corneum componentsEpidermal keratinsSkin barrier proteinsCorneocyte componentsSurface keratinsSkin surface lipids
02

Mechanism of action

Keratolytic agents act by increasing the moisture content of the skin and dissolving the intercellular cement (desmosomes) that binds corneocytes in the stratum corneum, thereby facilitating the shedding of skin cells (StatPearls, 2023). Some agents specifically target the hydrogen bonds in keratin proteins to soften the skin surface and improve texture (PubChem, 2024).

03

Biological functions

Barrier functionStructural integrityProtectionDesquamationHydration
04

Disease associations

HyperkeratosisPsoriasisIchthyosisAcneDermatophytosisKeratosis pilaris
05

Safety considerations

Skin irritationErythemaIncreased sensitivity to UV radiationImpaired barrier functionChemical burns (at high concentrations)
06

Interacting drugs

Salicylic acid

6 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Keratin 1/10 expressionKeratin 6/16 expressionCorneocyte morphologySkin hydration levels

Beyond the preview

Go deeper on Keratin and other skin surface components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin and other skin surface components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call